A MULTICENTRIC PHASE II RANDOMISED STUDY OF ORAL VINORELBINE (VRL) PLUS HYDROCORTISONE (HC) AND INTRAVENOUS (IV) VRL PLUS HC AS FIRST-LINE CHEMOTHERAPY OF METASTATIC ANDROGEN-INDEPENDENT PROSTATE CANCER (AIPC)

Autor:	M. Brandely, A. Caty, F. Lesaunier, S. Culine, Ján Kliment, Tomasz Demkow, F. Kasiborski, R. P. Abratt
Rok vydání:	2008
Předmět:	Oncology medicine.medical_specialty business.industry Androgen independent prostate cancer Urology Internal medicine medicine First line chemotherapy Vinorelbine business medicine.drug Hydrocortisone
Zdroj:	European Urology Supplements. 7:230
ISSN:	1569-9056
DOI:	10.1016/s1569-9056(08)60636-3
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::b6b4df9acf8f9b01417fbd43c072cb7f https://doi.org/10.1016/s1569-9056(08)60636-3 Zobrazit plný text záznamu Full Text from ScienceDirect